Upgrade to SI Premium - Free Trial

Form EFFECT Kalaris Therapeutics,

April 14, 2026 6:04 AM
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 13, 2026 4:00 P.M.
Form: S-3
CIK: 0001754068
Company Name: Kalaris Therapeutics, Inc.
File Number: 333-294881

Categories

SEC Filings